Evidence map›Paper›PMID 42432329›Full record

ArticleOncogene2026

A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis.

Takao Morinaga, Shouko Hayama, Yuki Nakamura, Katsushige Kawase, Hideki Ikeda, Suguru Miyata, Megumi Mogi, Eri Katayama, Rikiya Nakamura, Masahito Kawazu

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takao MorinagaDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan. tmorinaga@chiba-cc.jp.ORCID http://orcid.org/0000-0002-0305-7008
Shouko HayamaDepartment of Breast Surgery, Chiba Cancer Center, Chiba, Japan.ORCID http://orcid.org/0000-0002-3171-3033
Yuki NakamuraDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Katsushige KawaseDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Hideki IkedaDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Suguru MiyataDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Megumi MogiDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Eri KatayamaDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Rikiya NakamuraDepartment of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
Masahito KawazuDivision of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan. mkawz-tky@umin.ac.jp.ORCID http://orcid.org/0000-0003-4146-3629

Funding

Chiba University (Chiba U) IFCU-2022-05Japan Agency for Medical Research and Development (AMED) JP23ama221528Japan Agency for Medical Research and Development (AMED) JP256f0137008Japan Agency for Medical Research and Development (AMED) JP25ck0106001sJapan Agency for Medical Research and Development (AMED) JP25ck0106055sMEXT | Japan Society for the Promotion of Science (JSPS) 21H02772MEXT | Japan Society for the Promotion of Science (JSPS) 21K08314MEXT | Japan Society for the Promotion of Science (JSPS) 22J22286MEXT | Japan Society for the Promotion of Science (JSPS) 24K11756MEXT | Japan Society for the Promotion of Science (JSPS) 25K11596MEXT | Japan Society for the Promotion of Science (JSPS) 25K19458
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC), particularly in metastatic cases, lacks effective therapeutic vulnerabilities. We previously identified TNS3-S as a variant of TNS3 that is selectively expressed in TNBC. Here, we show that TNS3-S expression is regulated by TGFβ signaling and CpG methylation at its regulatory region. Notably, TNS3-S expression is markedly elevated in lung-metastasized TNBC tumors compared to primary tumors. Knockout of TNS3-S suppressed lung metastasis and rendered the cells sensitive to anoikis, both of which were reversed by rescued expression of TNS3-S. Mechanistically, TNS3-S stabilizes focal adhesion kinase, thereby facilitating adhesion-mediated proliferative signaling. Exploratory analyses of TCGA cohorts suggested that reduced promoter CpG methylation correlates with increased TNS3-S expression and could be associated with poorer outcomes across several cancer types. Collectively, these findings identify TNS3-S as a metastasis-associated regulator that promotes tumor outgrowth in distant organs and raise the possibility that epigenetic de-repression contributes to its activation during disease progression.

Indexed as

Focal Adhesion Kinase 1Lung NeoplasmsTensinsTriple Negative Breast NeoplasmsAnimalsCell Line, TumorCell ProliferationDNA MethylationFemaleGene Expression Regulation, NeoplasticHumansMiceNeoplasm MetastasisPromoter Regions, GeneticProtein IsoformsSignal TransductionFocal Adhesion Kinase 1Protein IsoformsPTK2 protein, humanTensinsTNS3 protein, human

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.